The slow march of clinical biomarkers to become surrogate endpoints
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
27 April 2026
27 April 2026
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.